Introduction {#s1}
============

Members of the genus *Acinetobacter* are significant nosocomial pathogens. *Acinetobacter baumannii* and its two close relatives, *Acinetobacter pittii* and *Acinetobacter nosocomialis* account for the majority of *Acinetobacter* infections [@pone.0084680-Peleg1]. A number of reports have detailed the significant increase in resistance of *Acinetobacter* spp. to conventional antibiotics, including carbapenems, the main therapeutic alternative against multidrug resistant *Acinetobacter* infections [@pone.0084680-Karageorgopoulos1].

The worldwide emergence of carbapenem resistant *Acinetobacter* may be attributed to the spread of some risk resistant clones and the horizontal transmission of carbapenemase genes [@pone.0084680-Peleg1], [@pone.0084680-Woodford1]. Carbapenem-hydrolyzing class D β-lactamases (CHDLs) are the most concerning carbapenem resistant determinants in *Acinetobacter* spp [@pone.0084680-Peleg1]. OXA-58 is a widely spread CHDL that has been reported in *Acinetobacter* spp. from Europe [@pone.0084680-Poirel1], Argentina [@pone.0084680-Coelho1], Australia [@pone.0084680-Peleg2], the United States [@pone.0084680-Castanheira1] and many Asian countries [@pone.0084680-Mendes1]. Though OXA-58 shows only low carbapenem-hydrolyzing activity *in vitro*, the insertion sequence upstream of *bla* ~OXA-58~ enhances its transcription greatly and mediates resistance to carbapenems [@pone.0084680-Poirel2]--[@pone.0084680-Chen2].

*bla* ~OXA-58~ exists not only in *A. baumannii*, but also in *A. pittii* [@pone.0084680-Marti1], *A. nosocomialis* [@pone.0084680-Chen2], *Acinetobacter radioresistens* [@pone.0084680-Mendes2], *Acinetobacter junii* [@pone.0084680-Peleg2], and *Acinetobacter* phenon 6/ct13TU [@pone.0084680-Marti2]. *bla* ~OXA-58~ is usually plasmid-borne, which may explain its wide dissemination. It has been reported that OXA-58 producing *A. baumannii* from European countries are associated with carriage of plasmid replicase gene *rep*Aci1 [@pone.0084680-Towner1]. However, little is known about the replicon types of *bla* ~OXA-58~-carrying plasmids in *A. baumannii* and non-*baumannii Acinetobacter* spp. outside of Europe.

*bla* ~OXA-58~ is the second most frequently identified CHDL in *A. baumannii* in China. However, the current data is limited to simple epidemiological distribution [@pone.0084680-Wang1], [@pone.0084680-Zhou1]. In this study, we detailed characterized the genetic contexts surrounding *bla* ~OXA-58~ and the replicon typing of the *bla* ~OXA-58~-carrying plasmids in *Acinetobacter* spp. isolates from multiple cities in China.

Materials and Methods {#s2}
=====================

Bacterial Strains and Antimicrobial Susceptibility Testing {#s2a}
----------------------------------------------------------

Twelve non-duplicated *bla* ~OXA-58~-harboring *Acinetobacter* spp. isolates collected from six hospitals in five different cities in China between 2005 and 2010 were analyzed in this study ([Table 1](#pone-0084680-t001){ref-type="table"}). The genomic species identification was performed by sequence analysis of the 16S-23S rRNA intergenic spacer region [@pone.0084680-Chang1].

10.1371/journal.pone.0084680.t001

###### Basic information, epidemiological features and resistant genes of *Acinetobacter* spp. included in this study[a](#nt101){ref-type="table-fn"}.

![](pone.0084680.t001){#pone-0084680-t001-1}

  Strain         Species        Hospital (Cities)   Year   PFGEtype   ST    allelic profiles[b](#nt102){ref-type="table-fn"}                 *bla* ~OXA~ genes                    ESBLgenes
  -------- ------------------- ------------------- ------ ---------- ----- -------------------------------------------------- ------------------------------------------------ ---------------
  AP04         *A. pittii*        HZ (Hangzhou)     2009      A       ND                           --                                          *bla* ~OXA-58~                        Neg
  AP25         *A. pittii*        TZ (Taizhou)      2009      A       ND                           --                                          *bla* ~OXA-58~                        Neg
  AN113     *A. nosocomialis*     WZ (Wenzhou)      2009      B       ND                           --                                          *bla* ~OXA-58~                        Neg
  AN116     *A. nosocomialis*     WZ (Wenzhou)      2009      B       ND                           --                                          *bla* ~OXA-58~                        Neg
  AN119     *A. nosocomialis*     WZ (Wenzhou)      2009      C       ND                           --                                          *bla* ~OXA-58~                        Neg
  WA3        *A. baumannii*        WHC (Wuhan)      2008      E       363                 51-54-49-11-48-25-4                          *bla* ~OXA-58~, *bla* ~OXA-51~           *bla* ~PER-1~
  WA8        *A. baumannii*        WHC (Wuhan)      2008      E       363                 51-54-49-11-48-25-4                          *bla* ~OXA-58~, *bla* ~OXA-51~           *bla* ~PER-1~
  WH8144     *A. baumannii*        WH (Wuhan)       2010      D       91                   22-15-13-12-4-62-2                  *bla* ~OXA-58~, *bla* ~OXA-23~, *bla* ~OXA-51~        Neg
  JH01       *A. baumannii*        JH (Jinhua)      2005      D       91                   22-15-13-12-4-62-2                  *bla* ~OXA-58~, *bla* ~OXA-23~, *bla* ~OXA-51~        Neg
  JH02       *A. baumannii*        JH (Jinhua)      2005      D       91                   22-15-13-12-4-62-2                  *bla* ~OXA-58~, *bla* ~OXA-23~, *bla* ~OXA-51~        Neg
  AB212      *A. baumannii*        JH (Jinhua)      2009      D       91                   22-15-13-12-4-62-2                  *bla* ~OXA-58~, *bla* ~OXA-23~, *bla* ~OXA-51~        Neg
  AB222      *A. baumannii*        JH (Jinhua)      2009      D       91                   22-15-13-12-4-62-2                  *bla* ~OXA-58~, *bla* ~OXA-23~, *bla* ~OXA-51~        Neg
  LS0148     *A. baumannii*        LS (Lishui)      2005      ND      20                   1-15-13-12-4-12-2                                   *bla* ~OXA-51~                        Neg

^a^ Abbreviations: HZ, Hangzhou First hospital; TZ, Taizhou Hospital; WZ, The First Affiliated Hospital of Wenzhou Medical College; WHC, Wuhan Children Hospital; WH, Wuhan Tongji Hospital; JH, Jinhua Center Hospital; LS, Lishui People Hospital; ND: not defined; Neg: negative; Pos: positive.

^b^ Seven loci in the order of *gltA*-*gyrB*-*gdhB*-*recA*-*cpn60*-*gpi*-*rpoD*.

Imipenem and ticarcillin-susceptible clinical *A. baumannii* strain LS0148 (imipenem MIC, 0.5 mg/L; ticarcillin MIC, 16 mg/L), deposited in our laboratory, was used as the recipient for plasmid electrotransformation ([Table 1](#pone-0084680-t001){ref-type="table"}). A colistin-resistant mutant strain of *A. baumannii* LS0148 (colistin MIC, 64 mg/L) was used as the recipient for plasmid conjugation.

MICs were determined by the agar dilution method. Interpretation of the results was in accordance with the CLSI 2013 criteria.

All isolates present in this study were stored in the Department of Microbiology, the First Affiliated Hospital, College of Medicine, Zhejiang University. We obtained an exempt status from the Institutional Review Board of the First Affiliated Hospital, College of Medicine, Zhejiang University to use these strains to perform all experiments in this study.

PCR Experiments for the Resistance Genes {#s2b}
----------------------------------------

PCR assays for the presence of carbapenemase encoding genes (*bla* ~OXA-51~-like, *bla* ~OXA-58~-like, *bla* ~OXA-23~-like, *bla* ~OXA-40~-like, *bla* ~OXA-143~, *bla* ~IMP~, *bla* ~VIM~, *bla* ~SIM~ and *bla* ~NDM~) and ESBL genes (*bla* ~PER~ and *bla* ~SHV~) were performed as previously reported [@pone.0084680-AdamsHaduch1]--[@pone.0084680-Chen3].

Pulsed-field Gel Electrophoresis and Multilocus Sequence Typing Analysis {#s2c}
------------------------------------------------------------------------

The genetic relationship of the isolates was evaluated by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). The results of PFGE were interpreted as Tenover et al. recommended [@pone.0084680-Tenover1]. MLST was carried out using the scheme developed by Bartual et al. with some modifications to the primers of the alleles of *gyrB* and *rpoD* as we previously reported [@pone.0084680-Bartual1], [@pone.0084680-Fu1].

Plasmid Conjugation and Electrotransformation {#s2d}
---------------------------------------------

Plasmid conjugations were performed between OXA-58 producing *Acinetobacter* spp. as donors and a colistin-resistant mutant strain of *A. baumannii* LS0148 as the recipient. The transconjugants were selected on MH agar plates containing ticarcillin (100 mg/L) and colistin (10 mg/L).

The electrical pulse setting of plasmid electrotransformation was 1.8 kV, 25 µF, 200 Ω with Bio-Rad GenePulser Xcell system (Bio-Rad, Shanghai, China). *A. baumannii* strain LS0148 was used as the recipient. The transformants were selected on MH agar plates containing ticarcillin (100 mg/L).

S1 Nuclease-based Plasmid Analysis {#s2e}
----------------------------------

The plasmid size and the location of *bla* ~OXA-58~ were analyzed using the S1 nuclease-PFGE method as previously reported [@pone.0084680-Barton1]. The bacterial-imbedded gel slices were incubated with 10 U S1 nuclease (Takara, Dalian, China) for 40 minutes in 37°C water bath. The digestion products were separated by PFGE using Bio-Rad CHEF Mapper XA system (Bio-Rad, Shanghai, China) with switch times of 2.16S to 63.8S for 18 hours.

The separated DNA was transferred to a positive charged Nylon membrane (Millipore, Shanghai, China) and hybridized with a digoxigenin-labled *bla* ~OXA-58~ probe. The detection of hybrids was performed using enzyme immunoassay and NBT/BCIP coloration according to the manufacturer's instruction (Roche, Shanghai, China).

PCR-based Plasmid Replicon Typing {#s2f}
---------------------------------

The plasmid replicase genes were detected by multiplex PCR scheme developed by Bertini et al [@pone.0084680-Bertini1]. The novel replicase gene *rep*Aci10 was detected by a single PCR with primers designed in this study (Forward primer: 5′-TAGGACGTCAAGCATCTTA-3′; backward primer: 5′-TCGCTATCAAGAAGATCAC-3′).

Cloning Experiments {#s2g}
-------------------

The genetic contexts of *bla* ~OXA-58~ were determined by cloning and sequencing experiments. The plasmids or total DNA were digested by EcoRI or SacI. The digested fragments were inserted into corresponding sites of pET28a, and the ligation mixture was used for transformation. Transformants were selected on MH agar containing ampicillin 50 mg/L and kanamycin 50 mg/L. The *bla* ~OXA-58~-containing inserts were fully or partially sequenced to obtain the context of *bla* ~OXA-58~.

Nucleotide Sequence Accession Numbers {#s2h}
-------------------------------------

The novel insertion sequence IS*Aba20* has been submitted to the IS Finder Database (<http://www-is.biotoul.fr/>). The nucleotide sequences surrounding *bla* ~OXA-58~ of AN119, AP04, WA3 and WH8144 are deposited in the GenBank database under accession no. JQ241789 to JQ241792 respectively.

Results {#s3}
=======

Species Identification and Antimicrobial Susceptibility Profiles {#s3a}
----------------------------------------------------------------

The 12 OXA-58-producing *Acinetobacter* spp. isolates were assigned to three genomic species: *A. baumannii* (seven isolates), *A. nosocomialis* (three isolates) and *A. pittii* (two isolates), and showed various resistance profiles ([Table 1](#pone-0084680-t001){ref-type="table"} and [2](#pone-0084680-t002){ref-type="table"}). The five non-*baumanii Acinetobacter* displayed imipenem and meropenem susceptible. On the contrary, all of the *A. baumannii* isolates were imipenem and meropenem resistance. In general, the *A. baumannii* isolates were more frequently resistant to broad-spectrum cephalosporins, ampicillin/sulbactam, aminoglycosides, ciprofloxacin and minocycline than the five non-*baumanii Acinetobacter*.

10.1371/journal.pone.0084680.t002

###### The sizes and replicon types of *bla* ~OXA-58~-harboring plasmids, genetic contexts of *bla* ~OXA-58~, and MICs (mg/L) of represented strains[a](#nt103){ref-type="table-fn"}.

![](pone.0084680.t002){#pone-0084680-t002-2}

  Isolates[b](#nt104){ref-type="table-fn"}    Plasmidsize (kb)   *rep* genegroup[c](#nt105){ref-type="table-fn"}   Geneticcontextsof *bla* ~OXA-58~ [d](#nt106){ref-type="table-fn"}   IPM    MEM    FEP    CAZ     CTX    SAM    TZP     TIC     GEN     AMK      MIN       CIP
  ------------------------------------------ ------------------ ------------------------------------------------- ------------------------------------------------------------------- ------ ------ ----- ------- ------- ----- ------- ------- ------- ------- --------- ---------
  AP04                                               93                              *aci10*                                                       A                                   0.5    0.5     4      4      16      4     32     \>256    64       2     \<0.125   \<0.125
  AP25                                               52                              *aci10*                                                       A                                    1     0.5     2      4      16      2     16     \>256     2       2     \<0.125   \<0.125
  AN113                                             143                              *aci10*                                                       A                                   0.5     1      4      4      16      1     16     \>256   \>256     4        4        0.5
  AN116                                             143                              *aci10*                                                       A                                    1      2     16      8      32     16     128    \>256   \>256     4        4       0.25
  AN119                                              76                              *aci10*                                                       D                                    4      2      4      8      16      4     64     \>256    128      4       0.5      0.25
  WA3                                               101                              *aci10*                                                       C                                   \>32    8     256   \>256   \>256   64     256    \>256    64      16     \<0.125   \<0.125
  WH8144                                             55                                --                                                          B                                   \>32   \>32   128    32      64     128   \>256   \>256   \>256    256      64        64
  JH01                                               55                                GR8                                                         B                                   \>32   \>32   256    128     256    128   \>256   \>256   \>256   \>256     64        16
  AB212                                              55                                --                                                          B                                   \>32   \>32   32     64      128    32    \>256   \>256   \>256   \>256     32        16
  LS0148                                             --                           \[GR3, GR7\]                                                    --                                   0.5    0.5     2      4      16      2     16      16       1       2        8        16
  TAP04                                              93                       *aci10*, \[GR3, GR7\]                                                A                                    2      2      4      8      16      4     64     \>256    16       2        8        32
  TAP25                                              52                       *aci10*, \[GR3, GR7\]                                                A                                    2      1      4      8      16      4     64     \>256     4       4        8        32
  TAN113                                            143                       *aci10*, \[GR3, GR7\]                                                A                                    1      1      4      8      16      2     32     \>256   \>256     4        4        32
  TAN116                                            143                       *aci10*, \[GR3, GR7\]                                                A                                    1      2      4      4      16      2     16     \>256   \>256     4        4        32
  TAN119                                             76                       *aci10*, \[GR3, GR7\]                                                D                                    16     16     4      8      16     16     256    \>256    64       4        8        32
  TWA3                                              101                       *aci10*, \[GR3, GR7\]                                                C                                    16     8      4      8      16     16     256    \>256     1       2        8        16
  TWH8144                                            55                           \[GR3, GR7\]                                                     B                                    8      4      4      8      16      8     128    \>256    256     128       8        16
  TJH01                                              55                           \[GR3, GR7\]                                                     B                                    8      4      4      8      16      8     128    \>256    256     128       8        16
  TAB212                                             55                           \[GR3, GR7\]                                                     B                                    16     4      4      8      16      8     256    \>256    256     128       8        16

^a^ IPM, imipenem; MEM, meropenem; FEP, cefepime; CAZ, ceftazidime; CTX, cefotaxime; SAM, ampicillin/sulbactam; TZP, piperacillin/tazobactam; TIC, ticarcillin; GEN, gentamicin; AMK, amikacin; MIN, minocycline; CIP, ciprofloxacin.

^b^ The isolates with names starting with alphabet T- were transformants;

^c^ Brackets indicate that GR3 and GR7 replicases are present in the recipient strain LS0148.

^d^ The alphabet corresponded to four kinds of genetic structure displayed in [Figure 1](#pone-0084680-g001){ref-type="fig"}.

Molecular Epidemiology of the OXA-58-producing *Acinetobacter* spp. {#s3b}
-------------------------------------------------------------------

PFGE identified five pulsotypes among the 12 OXA-58-producing *Acinetobacter* spp. isolates ([Table. 1](#pone-0084680-t001){ref-type="table"}). Two *A*. *pittii* isolates from different hospitals showed a same pulsotype. Three *A*. *nosocomialis* isolates from a single hospital belonged to two pulsotypes. Seven *A. baumannii* isolates were divided into two pulsotypes, corresponding to two sequence types (ST91 and ST363). *A. baumannii* ST91 were identified from two hospitals in different cities (Wuhan and Jinhua). Moreover, ST91 were detected in *A. baumannii* collected from Jinhua Center Hospital in 2005 and 2009, implying probable endemic in this hospital.

Distribution of Resistance Genes {#s3c}
--------------------------------

The *A*. *pittii* and *A*. *nosocomialis* were negative for other carbapenemase genes and ESBLs. Intrinsic *bla* ~OXA-51~ was detected in all *A. baumannii* isolates. All *A. baumannii* ST91 isolates carried another CHDL gene *bla* ~OXA-23~. *bla* ~PER-1~ was detected in WA3 and WA8 ([Table 1](#pone-0084680-t001){ref-type="table"}).

The Plasmid Localization of *bla* ~OXA-58~ {#s3d}
------------------------------------------

The *bla* ~OXA-58~-probe hybridized with plasmid bands of different sizes, from ca. 52 kb to 143 kb. Isolates with same pulsotypes generally possessed same plasmid location of *bla* ~OXA-58~, except AP04 and AP25 ([Table 2](#pone-0084680-t002){ref-type="table"}).

The Transferability of *bla* ~OXA-58~-carrying Plasmids {#s3e}
-------------------------------------------------------

While plasmid conjugation ultimately failed, *bla* ~OXA-58~-carrying plasmids were successfully electro-transferred from all *Acinetobacter* spp. isolates to the recipient strain.

PCR detection of transformants found *bla* ~PER-1~ and *bla* ~OXA-23~ were not co-transferred with *bla* ~OXA-58~, suggesting these genes are not colocalized on a single plasmid.

The results of antimicrobial susceptibility testing are presented in [Table 2](#pone-0084680-t002){ref-type="table"}. Electrotransformation of *bla* ~OXA-58~-harboring plasmids into recipient strain LS0148 resulted in high resistance to ticarcillin (\>256 mg/L) and increased MICs of imipenem and meropenem (2 to 32 folds), but transformants retained similar MICs of cefepime, ceftazidime and cefotaxime when compared with that of the original LS0148 strain. The transformants of *A. nosocomialis* AN119 and all *A. baumannii* displayed higher MICs of imipenem and meropenem than transformants of *A. pittii* isolates and remaining *A. nosocomialis* isolates. Transformants TWH8144, TJH01, TAB212 also showed gentamicin and amikacin resistance, implying potential aminoglycosides resistant determinants are colocalized with *bla* ~OXA-58~ on the same plasmid.

Identification a Novel Plasmid Replicase Gene {#s3f}
---------------------------------------------

Further investigation of the *bla* ~OXA-58~-containing clone fragment of strain WA3 identified a novel plasmid replication protein gene ([Figure. 1](#pone-0084680-g001){ref-type="fig"}). This replication protein belonged to Rep-3 superfamily group. It shared similarity with two replication proteins deposited in GenBank database: *Acinetobacter* sp. RUH2624 (ZP_05826577; 100% amino acid identity) and *A. radioresistens* SH164 (ZP_06073941; 73% amino acid identity). We have designated this novel replicase gene as *rep*Aci10 herein. Of the available *A. baumannii* replicase genes in the current replicon typing scheme [@pone.0084680-Bertini1], *rep*Aci5 was most similar to *rep*Aci10 (66% nucleotide identity). Therefore, *rep*Aci10 should be assigned as a novel homolog group (GR20). No iteron was identified upstream of *rep*Aci10.

![Schematic map of the genetic contexts of *bla* ~OXA-58~.\
Structure A (AP04, AP25, AN113 and AN116); Structure B (WH8144, JH01, JH02, AB212 and AB222); Structure C (WA3 and WA8); Structure D (AN119). The dash line indicates the truncated positions of IS*Aba3*-like element. The thick vertical lines indicate the Re27 recombination points. The location and orientation of primers are indicated by arrows and numbers, being consistent with [Table 2](#pone-0084680-t002){ref-type="table"}. *orf1*, DNA-binding response regulator gene; *orf2*, putative exodeoxyribonuclease VII large subunit gene; *orf3*, ParA family protein gene; *orf4*, putative inner membrane protein gene; *orf5*, putative chromate transporter gene; *orf6*, putative cytoplasmic protein gene. GenBank accession No.: A, JQ241790; B, JQ241792; C, JQ241791; D, JQ241789. The figure is not to scale.](pone.0084680.g001){#pone-0084680-g001}

Using the current PCR-based replicon typing scheme of *A. baumannii* [@pone.0084680-Bertini1], only GR8 was detected in strain JH01 and JH02 from the 12 OXA-58 producing *Acinetobacter* spp. ([Table 2](#pone-0084680-t002){ref-type="table"}). GR3 and GR7 are the intrinsic plasmid *rep* genes of recipient strain LS0148. No other replicase genes were detected in the transformants except for the intrinsic plasmid replicase genes of LS0148 (GR3 and GR7), suggesting the *bla* ~OXA-58~-carrying plasmids do not belong to any previously known replicon group. The novel replicase gene *rep*Aci10 was detected in *A. pittii* (AP04, AP25), *A. nosocomialis* (AN113, AN116 and AN119), *A. baumannii* (WA3, WA8) and their transformants ([Table 2](#pone-0084680-t002){ref-type="table"}).

Genetic Contexts of *bla* ~OXA-58~ {#s3g}
----------------------------------

Four kinds of genetic contexts of *bla* ~OXA-58~ were identified among 12 *Acinetobacter* spp. ([Figure. 1](#pone-0084680-g001){ref-type="fig"}). Structure A included two *A. pittii* isolates (AP04, AP25) and two *A. nosocomialis* isolates (AN113 and AN116). Structure B encompassed all *A. baumannii* ST91 isolates of WH8144, JH01, JH02, AB212 and AB222. Structure C encompassed *A. baumannii* isolates WA3 and WA8. Structure D included *A. nosocomialis* isolate AN119. The most notable difference was the IS elements located upstream of *bla* ~OXA-58~. In structure A, an intact IS*Aba3*-like element was exclusively present upstream of *bla* ~OXA-58~. However, in structure B, C and D, the IS*Aba3*-like element upstream of *bla* ~OXA-58~ was truncated at a same position (58 bp downstream of the start codon of the transposase gene of IS*Aba3*-like element) by IS*Our1*, IS*1008* and IS*15* respectively. All of the latter three IS elements belong to the IS*6* family. The transformants of the plasmids with the structure of IS*6* family-ΔIS*Aba3*-like-*bla* ~OXA58~ displayed a much higher increase in imipenem MICs (16--32 folds) than those with intact IS*Aba3*-like-*bla* ~OXA58~ (2--4 folds) ([Table 2](#pone-0084680-t002){ref-type="table"}).

IS*Aba3*, *araC1* (putative transcriptional regulator gene) and *lysE* (putative threonine efflux protein gene) were identified downstream of *bla* ~OXA-58~ in all isolates. However, the *araC1* and *lysE* in structure B were disrupted by IS*Aba20* and Tn*aphA6* respectively. IS*Aba20* is a novel insertion sequence of IS*3* family, and is 1199 bp long with two ORFs. The insertion of IS*Aba*20 into *araC1* generated two 4-bp direct repeats (CTTA). Tn*aphA6* was a composite transposon, comprising an aminoglycoside *O*-phosphotransferase gene, *aphA6*, and two flanked IS*Aba125* of same orientation. Tn*aphA6* was inserted into *lysE* and generated two 3-bp target site duplications (CTG).

It has been reported that the acquisition of *bla* ~OXA-58~ is usually associated with recombination events characterized by the presence of two 27-bp sequences named Re27-1 and Re27-2 [@pone.0084680-Poirel2]. In structure A, we identified a similar Re27-1 sequence located 8 bp downstream of the intact IS*Aba3*-like element (5′-ATTTAACATAATGGCTGTTATACGAAA-3′), and an imperfect Re27-2 sequence (5′-ATTTAACATAATGGTGGTTATACGCAA-3′) was just adjacent to the downstream of *lysE*. In structure D, a pair of 29-bp imperfect probable recombination points were identified 748 bp downstream of IS*15* element (5′-ATTTAACATAATGGTGGTTATGCGAAGTC-3′) and adjacent to *lysE* (5′-ATTTAACATAATGGGCGTTATGCGAAGTC-3′). In structure B and C, we failed to find pairs of Re27-like regions.

Discussion {#s4}
==========

Previous studies reported that European clone II lineage OXA-23-producing *A. baumannii* CC92 was the most popular carbapenem-resistant clone in China [@pone.0084680-Fu1], [@pone.0084680-He1]. The OXA-58 producing *A. baumannii* of European clone II has been reported in Italy [@pone.0084680-DArezzo1], Greece [@pone.0084680-Gogou1] and China [@pone.0084680-Zhang1]. However, only *A. baumannii* ST91 and ST363 were identified in this study without any European clone II lineage isolates. We have showed ST91 strains contain both *bla* ~OXA-23~ and *bla* ~OXA-58~, and possess multidrug resistance to carbapenems, broad-spectrum cephalosporins, aminoglycosides, ampicillin/sulbactam, minocycline, and ciprofloxacin. Moreover, ST91 was detected in two cities. Therefore, we speculate ST91 is a potential risk multidrug resistant clone that is widely present in China. A larger scale epidemiological investigation would be necessary to fully elucidate the true distribution of ST91 in China.

Gentamicin and amikacin resistance were observed in transformants of *A. baumannii* ST91. The analysis of nucleotide sequence around *bla* ~OXA-58~ identified an aminoglycoside *O*-phosphotransferase gene, *aphA6*. The gentamicin and amikacin resistance gene *aphA6* was first reported in *A. baumannii* in 1988 [@pone.0084680-Martin1]. Nigro et al. recently reported *aphA6* located in a potential transposon Tn*aphA6*, flanked by two copies of IS*Aba125* [@pone.0084680-Nigro1]. An identical transposon was identified in our study and Tn*aphA6* was inserted into a putative threonine efflux protein gene *lysE*. It should be noticed that the susceptible *A. baumannii* could develop carbapenem and amikacin resistance simultaneously via the *bla* ~OXA-58~ and *aphA6* co-harboring plasmid.

Bertini et al. reported the *bla* ~OXA-58~ harboring plasmids could be classified into various groups, including GR2 (Aci1), GR3 (Aci3 and Aci7), GR4 (Aci4) and GR5 (Aci5) [@pone.0084680-Bertini1]. Using the same typing scheme, Towner reported that OXA-58 producing *A. baumannii* from European countries were commonly associated with Aci1, Aci3, Aci4, and AciX [@pone.0084680-Towner1]. However, the *bla* ~OXA-58~-carrying plasmids in this study did not belong to any known replicon groups, and a novel replicase gene *rep*Aci10 was identified This suggests that the spread of *bla* ~OXA-58~ in China may be mediated by unique plasmids being different from those of Europe. Meanwhile, the plasmids of *rep*Aci10 are viable in different genomic species of *Acinetobacter* and may contribute to horizontal transmission of resistance genes. However, the replicase genes of the plasmids of *A. baumannii* ST91 remain unknown and further complete plasmid sequencing is in process.

The acquisition of *bla* ~OXA-58~ is associated with a recombination event at site of Re27 sequence [@pone.0084680-Poirel2]. However, the pairs of Re27 sequence around *bla* ~OXA-58~ were absent in partial isolates in this study, suggesting it may have been lost during plasmid evolution.

It is speculated that the insertion of other IS element into IS*Aba3*-like could generate a hybrid promoter to enhance the transcription of *bla* ~OXA-58~ and mediate greater carbapenem resistance than the intact IS*Aba3*-like element as previously reported [@pone.0084680-Poirel2]--[@pone.0084680-Chen2], [@pone.0084680-Boo1]. In this study, for plasmids that the IS*Aba3*-like element was disrupted by IS*Our1*, IS*1008* or IS*15*, their corresponding transformants showed a high increase in imipenem MICs (16--32 folds), while for plasmids that the IS*Aba3*-like element was intact, the imipenem MICs of their corresponding transformants were only slightly increasing (2--4 folds). The special structure of IS*6* family-ΔIS*Aba3*-like-*bla* ~OXA-58~ is different from IS*Aba2*, IS*18*, IS*Aba125*, IS*Aba1* and IS*Aba825* that is usually inserted into IS*Aba3*-like in *Acinetobacter* spp. from Europe [@pone.0084680-Poirel2], [@pone.0084680-Ravasi1], [@pone.0084680-Evans1].

In conclusion, the genetic background of OXA-58-producing *Acinetobacter* spp. in China was diverse, and the multidrug resistant *A. baumannii* ST91 is a potential risk clone. The STs of *A. baumannii*, replicon typing of *bla* ~OXA-58~-harboring plasmids and genetic contexts of *bla* ~OXA-58~ were distinct from those of Europe, implying the unique evolution and transmission pattern of *bla* ~OXA-58~ in *Acinetobacter* spp. in China.
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